📰
Politics
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
📅23 September 2026 at 19:31
📰TechCrunch
👁️4 views
Share:
📰
Article Preview
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
🎧
Listen to Preview
Audio version available
🔇
Audio Reader
Not supported in this browser
Want the full story?
Click below to load the complete article with full details, analysis, and context.
Share this story
Share:
Source: This article was originally published by TechCrunch. All rights reserved to the original publisher.
Comments
Loading comments...
Related Stories
Stay Updated
Get the latest Nigerian news delivered to your inbox.